Background: Chikungunya virus (CHIKV) and dengue virus (DENV) co-circulate in areas endemic with the Aedes mosquito vectors. Both viruses cause similar illnesses which may be difficult to distinguish clinically. CHIKV is also associated with persistent arthralgia. Objectives: To compare and describe factors which differentiate between DENV and CHIKV infections on presentation; and to describe predictors of persistent arthralgia in CHIKV patients. Study design: Patients aged >14 years diagnosed with acute CHIKV and DENV infections in Kuala Lumpur, Malaysia were retrospectively identified. Clinical and laboratory data were obtained from medical records, and compared. CHIKV patients were telephoned 15-24 months later and interviewed about persistent symptoms. Logistic regression analysis was performed. Results: A total of 53 CHIKV and 113 DENV patients were included. CHIKV patients were older and more likely to be female. CHIKV was independently associated with arthralgia and rash, while DENV was associated with myalgia, raised aspartate transaminase, and leucopaenia. Forty CHIKV patients were followed up, with a median duration of self-reported arthralgia of 3 months (range, 0-24 months). Eighteen (45%) had persistent arthralgia beyond 4 months, for which age >40 years was an independent predictor. At 1 year, 9 (22.5%) patients had arthralgia. Conclusion: In Kuala Lumpur, selected clinical and laboratory predictors help to distinguish between DENV and CHIKV infections. Persistent arthralgia was a frequent sequel of CHIKV infection in this cohort.
differentiate between the two diseases assumes greater importance, in view of their different clinical courses and outcomes. Comparative clinical studies between the two diseases in adults are scarce, often limited by small numbers, and differences in clinical presentations in one country may not be applicable to another.
Although the acute symptoms of CHIKV generally last about a week and are self-limiting, an earlier study from South Africa suggested that some patients do experience chronic arthralgia lasting for months to years. 8 The recent global outbreaks have brought this potential burden of long-term morbidity into focus. 9.10 As there are conflicting reports on how common persistent arthralgia is, further follow-up data from different cohorts would be useful.
Objectives
This study aimed to compare and describe factors which would help differentiate between DENV and CHIKV infections on presentation. A secondary objective was to ascertain the rate and describe predictors of persistent arthralgia in CHIKV patients.
Study design
This study was conducted at the University Malaya Medical Centre, in Kuala Lumpur, Malaysia. Patients aged >14 years with acute CHIKV and DENV infections confirmed by the diagnostic virology laboratory from April 2008 to July 2009 were retrospectively identified. Two DENV cases were randomly selected for each CHIKV case identified. Confirmed CHIKV infections had a positive culture, positive PCR detection of the E1 gene, 11 or positive IgM by indirect immunofluorescence. 4 As serum samples were taken at different time-points after onset of symptoms for each patient, not all CHIKV patients were tested by all three methods. We used a positive viral culture as specific confirmation of acute DENV infection, as a single positive dengue IgM may also indicate infection up to several months ago. Cultures were performed using Vero (African green monkey kidney) and C6/36 (Ae. albopictus) cells, and identified with polyclonal anti-CHIKV or monoclonal anti-DENV antibodies. The medical records of the identified patients were reviewed for demographic, clinical and laboratory data on initial presentation at the hospital. Ethical approval for the study was obtained from the hospital's Medical Ethics Committee.
For follow-up, CHIKV patients were contacted by telephone in 2011. Informed consent was first obtained. The interview was conducted using a predefined structured questionnaire. Data collected included duration of symptoms, the intensity of self-reported pain during the initial attack and chronic phases, and impact of symptoms on activities of daily living. Declarative numerical rating scales (NRS) were used to evaluate the pain intensity during the acute and chronic phases. The pain score ranges between 0 and 10, and were categorized into pain-free (0), mild (1-3), moderate (4-6) and severe (7) (8) (9) (10) . 12 In two previous studies, including one from Malaysia, >95% of patients were pain-free by 3 months. 3, 5 For this study, persistent arthralgia was defined as the presence of selfreported pain more than 4 months after the acute illness.
Data were analyzed using SPSS 15.0 (SPSS Inc., Chicago, IL). For univariate analysis, Mann-Whitney U tests were used for continuous variables, and Fisher's exact or chi-squared tests were used for categorical variables. Logistic regression analysis was carried out for two separate outcomes: first, to predict either DENV or CHIKV infection; and second, to predict CHIKV patients with persistent arthralgia. Univariate logistic regression was initially carried out for selected variables, based on previous studies and biological plausibility. Odds ratio (OR) and 95% confidence intervals (CI) were calculated. Those variables significant at p < 0.2 were entered into the multivariate regression model, and retained based on the likelihood ratio test. Final values of p < 0.05 were considered significant. The final model was then tested for collinearity, and assessed with the Hosmer and Lemeshow goodness-of-fit test and calculation of the area under the receiver operating characteristic curve.
Results
A total of 60 patients with confirmed CHIKV and 120 patients with confirmed DENV were identified from laboratory records, for which medical records could not be located for 7 CHIKV and 7 DENV patients. A total of 53 CHIKV patients and 113 DENV patients were therefore included in the study. For CHIKV, 35 patients were diagnosed by IgM, 12 by PCR, and 17 by culture, or a combination of these. The predominant DENV serotypes were DENV1 (46, 40.7%) and DENV2 (46, 40.7%), followed by DENV3 (20, 17.7%) and DENV4 (1, 0.9%). The patients' demographic details are shown in Table 1 . Compared to DENV patients, CHIKV patients were significantly older and more likely to be female. There was a significant difference in ethnicity, due to a greater number of non-Malaysian nationals (n = 28, 24.8%) diagnosed with DENV. These comprised patients from Bangladesh (n = 12), Nepal (n = 11), Indonesia (n = 4), and Vietnam (n = 1). There were 82 (72.6%) admissions in the DENV group, and only 12 (22.6%) in the CHIKV group ( 2 = 36.6, p < 0.001).
Clinical and biochemical test comparisons between CHIKV and DENV patients at presentation are shown in Table 2 . The 5 most frequently reported presenting symptoms in CHIKV patients were fever (96.2%), arthralgia (96.2%), rash (58.5%), myalgia (32.1%), and headache (22.6%). DENV patients commonly reported fever (96.4%), myalgia (74.3%), nausea/vomiting (66.4%), headache (57.5%), and diarrhoea (39.8%). On univariate analysis, DENV patients were more likely to have headache, nausea/vomiting, diarrhoea, and myalgia; while CHIKV patients were more likely to report rash and arthralgia. CHIKV patients had significantly lower aspartate transaminase levels (AST; 114.0 vs. 144.9 U/L, p < 0.001), higher white cell counts (5.9 vs. 2.9 × 10 9 /L, p < 0.001), and higher platelet counts (200.9 vs. 78.5 × 10 9 /L, p = 0.001).
On multivariate analysis, CHIKV was associated with arthralgia (OR 159.0, 95% CI 17. Patients with CHIKV were then telephoned for follow-up interviews, a mean duration of 20 ± 2 months (range, 15-24 months) after the initial illness. Out of 53 CHIKV patients, 40 patients were interviewed. Of the 13 patients not interviewed, 10 had the incorrect contact numbers in their medical records, 1 patient had migrated, and 2 patients had died -one death was associated with CHIKV, as previously described, 13 while the other death was due to unrelated causes. At the time of interview, 31 (77.5%) were painfree, while 9 (22.5%) still had arthralgia, of which 6 had mild pain and 3 had moderate pain. In 17 (42.5%) patients, arthralgia affected at least one daily activity for <30 days, 20 (50%) patients were affected for 30-90 days, and 3 (7.5%) were affected for >90 days. The median self-reported duration of arthralgia was 3 months (range, 0-24 months), with 18 (45.0%) of the patients reporting persistent arthralgia beyond 4 months, and 9/40 (22.5%) beyond 1 year.
Analysis of selected predictors of persistent arthralgia is shown in Table 3 . Only age >40 years was shown to be an independent Table 1 Demographic characteristics of patients with Chikungunya (n = 53) and dengue (n = 113).
Factor
Dengue patients (n, %) Chikungunya patients (n, %) predictor (OR 8.0, 95% CI 1.5-43.4). Gender, pre-existing rheumatological condition, and presence of arthritis, number of joints involved, and severe pain during acute illness were not significantly associated with persistent arthralgia.
Discussion
Studies comparing adult patients with DENV or CHIKV are few, due to the previous relative rarity of CHIKV and its occurrence in countries with historically limited diagnostic capacity. The few available studies indicate variations in different countries, which prompted the present study to be carried out in Malaysia. We found demographic differences between patients with DENV or CHIKV. CHIKV patients were older, as seen in other sites. 2, 14, 15 The endemic nature of DENV in Malaysia results in increasing seroprevalence to DENV with age, to >90% by 45 years, 16 so DENV disease is more commonly seen with decreasing age. For CHIKV, there was a low level of population immunity in Malaysia prior to the recent outbreaks, 17 while severity of CHIKV increases with age. 1, 9 Thus, CHIKV likely affected people across all ages, with the older, more severely affected patients more likely to seek medical care than younger, milder cases. This may explain the apparent age disparity between the two sets of patients seen in this study.
It is not clear why there were more males and non-Malaysians with DENV, and more females with CHIKV. Recent CHIKV strains have adapted to Ae. albopictus. 18 The differing relative roles of Ae. aegypti and Ae. albopictus in transmitting DENV and CHIKV, and factors such as biting habits and geographical distribution, may contribute to the epidemiological differences between the two diseases in urban centres. Further investigation is required into this underexplored area.
For differentiating between the two diseases, we found that arthralgia and rash were associated with CHIKV, while myalgia, raised AST and leucopaenia were associated with DENV. Arthralgia was seen in 96.2% of our CHIKV patients and 30.1% of DENV patients, and strongly predicted CHIKV, as in Singapore, 14 France, 19 and Thailand. 20, 21 However, in Sri Lanka 2 and Gabon, 22 high rates of arthralgia were reported in 67-84% of DENV patients, making arthralgia unhelpful as a distinguishing feature. Raised AST and leucopaenia have been previously associated with DENV, 14 but we did not find thrombocytopaenia to predict DENV as reported by others. 14, 19 While some studies may have failed to detect differences due to small samples, a large study from Gabon concluded that the two diseases were clinically indistinguishable. 22 Previous studies of arthralgia persisting after CHIKV infection have shown rates varying from >55% after 15-24 months in France and Réunion, 10, [23] [24] [25] to 32-46.3% at 10-12 months in Italy and Karnataka, India, 26,27 to 11.6% at 1 year in Maharashtra, India, 28 to 0-4.1% at 3 months in Gabon 3 and Malaysia. 5 Within Malaysia, our present study of an urban population (median age, 50.7 years) showed persisting arthralgia in 18/40 (45%) patients at 4 months, whereas our previous study in a rural Malaysian cohort (median age, 48 years) found no arthralgia beyond 3 months (p < 0.001). 5 Although follow-up studies are hard to compare due to different definitions of persistent arthralgia and duration of follow-up, the wide variations reported, even within the same country, likely reflects differences in population genetics, cultural and behavioural factors, and possibly viral virulence.
We found that age >40 years predicted chronic arthralgia. Older age is consistently described as a risk factor in other studies across settings. 8, 10, 24, 27 Defects in regulation of the immune response leading to persisting inflammation may underlie this. 29 Other reported associated factors include severe initial joint pain, 10 longer duration of acute symptoms, 24 pre-existing osteoarthritis, 10 and female gender. 30 In conclusion, we have described clinical and laboratory parameters that aid in the clinical differentiation between CHIKV and DENV in Malaysia. The ability to make clinical diagnoses in resource-limited countries is still important in the continuing absence of rapid, reliable and affordable tests for common causes of acute undifferentiated fever. 31 Persistent arthralgia was frequently reported in this urban cohort. Clinical differences between DENV and CHIKV, and progression of CHIKV infection to persistent arthralgia vary greatly between settings. Data from other cohorts in CHIKV-affected areas continue to be valuable in understanding the reasons for this.
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